Differences in Cardiometabolic Proteins in Pregnancy Prioritize Relevant Targets of Preeclampsia.

Kathryn J Lindley Andrew S Perry Marni B Jacobs Lauren E Petty Alexander G Bick Shilin ZhaoClaire BarkerVictor G Davila-Roman Sadiya S Khan Sarah S Osmundson Kahraman Tanriverdi Jane E Freedman Jennifer E Below Ravi V Shah Louise C Laurent

Published in: Arteriosclerosis, thrombosis, and vascular biology (2024)

These results demonstrate the value of performing targeted proteomics using a panel of cardiovascular biomarkers to identify biomarkers relevant to preeclampsia pathophysiology and highlight the need for larger multiomic studies to define modifiable pathways of surveillance and intervention upstream to preeclampsia diagnosis.

Keyphrases

early onset
pregnancy outcomes
randomized controlled trial
mass spectrometry
pregnant women
cancer therapy